Emerald Mutual Fund Advisers Trust’s NovoCure NVCR Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,173	Closed	-$248K	–	219
2025 Q3	$248K	Sell	19,173 -200,411	-91%	-$2.68M	0.01%	186
2025 Q2	$3.91M	Sell	219,584 -104,376	-32%	-$1.82M	0.24%	109
2025 Q1	$5.77M	Sell	323,960 -1,295	-0.4%	-$29.4K	0.41%	84
2024 Q4	$9.69M	Buy	+325,255	New	+$6.88M	0.59%	66

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's NVCR Position: Q4 2025 in Review

Emerald Mutual Fund Advisers Trust sold out of NovoCure (NVCR) in Q4 2025, closing a stake of 19,173 shares — an estimated $248K sold.

Emerald Mutual Fund Advisers Trust first reported a position in NVCR in Q4 2024 and held it in 4 quarters. The position peaked at $9.69M in Q4 2024. 238 funds tracked by Wall St. Rank hold NVCR as of Q4 2025.

Emerald Mutual Fund Advisers Trust reported no remaining NovoCure position as of Q4 2025 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 19,173 NovoCure shares in Q4 2025, an estimated $248K.
Emerald Mutual Fund Advisers Trust first reported a position in NovoCure in Q4 2024 and held it in 4 quarters.
Emerald Mutual Fund Advisers Trust's NovoCure position peaked at $9.69M in Q4 2024.
238 funds tracked by Wall St. Rank held NovoCure as of Q4 2025.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2025, filed 9 Feb 2026.